Skip to main content Help with accessibility Skip to main navigation

Filgotinib

Indication

Treating moderately to severely active ulcerative colitis - NICE TA792

NICE TA792 - Filgotinib for treating moderately to severely active ulcerative colitis

Red

Brand:

Nice TA:

792

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Gastro-intestinal system

Background

1.1 Filgotinib is recommended, within its marketing authorisation, as an option for treating moderately to severely active ulcerative colitis in adults:

  • when conventional or biological treatment cannot be tolerated, or

  • if the disease has not responded well enough or has stopped responding to these treatments, and

  • if the company provides filgotinib according to the commercial arrangement.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 15 - Jul - 2022